Post by Axmed

Each year, hundreds of thousands of children across sub-Saharan Africa die from infections that are both preventable and treatable. Interventions like azithromycin distribution can significantly reduce child mortality in high-burden settings. The solutions already exist. The challenge is how to deliver them, reliably, affordably, and at scale. That’s why today, we’re announcing a $7 million supply agreement to support the delivery of quality-assured medicines through the Resiliency through Azithromycin for Children (REACH) programme in Burkina Faso. Through the agreement, Axmed will support the country’s participation in the REACH programme, helping to expand coverage and reduce preventable child deaths. 𝗢𝘃𝗲𝗿 𝘁𝗵𝗲 𝗻𝗲𝘅𝘁 𝘁𝗵𝗿𝗲𝗲 𝘆𝗲𝗮𝗿𝘀, 𝘂𝗽 𝘁𝗼 𝟭𝟲 𝗺𝗶𝗹𝗹𝗶𝗼𝗻 𝗱𝗼𝘀𝗲𝘀 𝗼𝗳 𝗲𝘀𝘀𝗲𝗻𝘁𝗶𝗮𝗹 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 𝘄𝗶𝗹𝗹 𝗯𝗲 𝗱𝗲𝗹𝗶𝘃𝗲𝗿𝗲𝗱 𝘁𝗼 𝗰𝗵𝗶𝗹𝗱𝗿𝗲𝗻 𝘂𝗻𝗱𝗲𝗿 𝗳𝗶𝘃𝗲 𝗮𝗰𝗿𝗼𝘀𝘀 𝘁𝗵𝗲 𝗰𝗼𝘂𝗻𝘁𝗿𝘆. By working directly through Burkina Faso’s national systems, this model preserves sovereignty while unlocking global market access, competitive pricing, and quality assurance at scale. Our digital procurement program aggregates demand, increases market transparency, and reduces supply chain fragmentation, enabling governments to secure high-quality medicines more efficiently and independently. This is what country-led, system-enabled access looks like. Read more: https: //https://lnkd.in/enm6im-g #AxmedVoices #GlobalHealth #AccessToMedicines #HealthSystems